Neurodevelopmental Outcomes at Five Years After Early-Onset Fetal Growth Restriction: Analyses in a Dutch Subgroup Participating in a European Management Trial. Issue 8 (August 2019)

• Record Type: Journal Article
• Authors: Pels, A.; Knaven, O. C.; Wijnberg-Williams, B. J.; Eijsermans, M. J. C.; Mulder-de Tollenaer, S. M.; Aarnoudse-Moens, C. S. H.; Koopman-Esseboom, C.; van Eyck, J.; Derks, J. B.; Ganzevoort, W.; van Wassenaer-Leemhuis, A. G.
• Is Part Of: Obstetrical & gynecological survey. Volume 74:Issue 8(2019)
• Publication Date: 2019-08
• Subjects: Obstetrics -- Periodicals; Gynecology -- Periodicals; Generative organs, Female -- Surgery -- Periodicals; 618
• DOI: 10.1097/01.ogx.0000578692.65024.12
• Languages: English
• ISSNs: 0029-7828

Abstract

Abstract : (Abstracted from Eur J Obstet Gynecol Reprod Biol 2019;234:63–70) Uteroplacental insufficiency is the most common cause of fetal growth restriction (FGR), with potentially critical consequences for both the mother and fetus. Definitions of uteroplacental insufficiency vary between an antenatal diagnosis reflecting the placental dysfunction and a postnatal diagnosis based on birth weight.